|
Re: Age, MoCA and CKD
|
5
|
Resverlogix Corp.
|
Nov 19, 2019 02:59PM
|
|
Re: Zenith Epigenetics Triple Negative Breast Cancer Clinical Data Highlighted in an Oral Discussion at the ASCO Conference
|
5
|
Zenith Epigenetics
|
Jun 21, 2022 09:16AM
|
|
Re: Toxicity
|
5
|
Zenith Epigenetics
|
Mar 26, 2023 10:12AM
|
|
Re: Pfizer
|
5
|
Zenith Epigenetics
|
Jun 05, 2020 03:48PM
|
|
https://pace-cme.org...
|
5
|
Resverlogix Corp.
|
Dec 07, 2017 09:21AM
|
|
Re: Cases of COVID-19 infection are on the rise again in Brazil.
|
5
|
Resverlogix Corp.
|
Jan 05, 2022 11:55AM
|
|
Re: Rebuys start at $2.28
|
5
|
Resverlogix Corp.
|
Aug 09, 2018 04:51PM
|
|
Re: Roth research report
|
5
|
Resverlogix Corp.
|
Oct 31, 2018 09:26PM
|
|
Zenith funding???
|
5
|
Zenith Epigenetics
|
Jun 15, 2019 01:28PM
|
|
Re: Sales could take a hit
|
5
|
Resverlogix Corp.
|
Apr 18, 2023 11:30AM
|
|
Re: Comments on the AGM
|
5
|
Resverlogix Corp.
|
Nov 09, 2019 09:36AM
|
|
Re: Concerns Mount Over COVID-19 'Rebounds' After Treatment With Pfizer's Paxlovid
|
5
|
Resverlogix Corp.
|
Jun 02, 2022 03:00PM
|
|
Gilead
|
5
|
Resverlogix Corp.
|
Jan 08, 2018 05:14PM
|
|
Re: https://scr.zacks.co...
|
5
|
Zenith Epigenetics
|
May 04, 2020 11:22AM
|
|
Re: HL Acquires Additional Securities of RVX
|
5
|
Resverlogix Corp.
|
May 22, 2021 12:58PM
|
|
Re: time to add/3 vs 5 pt. MACE
|
5
|
Resverlogix Corp.
|
Mar 21, 2018 12:05PM
|
|
Re: MERCK….
|
5
|
Resverlogix Corp.
|
Oct 01, 2021 01:59PM
|
|
Re: Exceptionally good news
|
5
|
Resverlogix Corp.
|
Nov 18, 2019 11:37AM
|
|
Re: Checklist to Management
|
5
|
Resverlogix Corp.
|
Jul 30, 2016 11:46AM
|
|
Re: What are we expecting to learn from scheduled webcast ? ( first week of March)
|
5
|
Resverlogix Corp.
|
Feb 20, 2016 06:02PM
|
